DEA and a Two Hour Offering on PDMP and Alternative Opioid Therapy in Dentistry

Richard L. Wynn, PhD

Richard L. Wynn, BS Pharm, MS, PhD is Professor of Pharmacology at the Dental School, University of Maryland, Baltimore. His course directorships include post-graduate pediatric pharmacology at the dental school. He taught the Basic Science Component of the AGD Masters Program for the University of Florida continuing education from CDP 10 through CDP31. He has to his credit over 400 publications including original research articles, textbooks, book chapters, and monographs. He has given continuing education seminars since 1980 to dental professionals in the US, Canada, Mexico and Europe, including Sick Kids Hospital Program in Toronto. His research laboratories have contributed to the development of intravenous anesthetics, inhalant anesthetics and agents for control of chemotherapy-induced nausea. He is the lead author and chief editor of Drug Information Handbook for Dentistry, since its inception, now in its 29th edition, published by LexiComp, Inc/ WoltersKluwer. He has been a consultant to the Maryland State Board of Dental Examiners for course development for opiate prescribing and disposal for Maryland licensees.

Course Description:

Beginning in June, 2023, dentists will be required to check a box on their online DEA registration form – regardless of whether a registrant is completing their initial registration application or renewing their registration – affirming that they have completed a new one-time eight-hour training requirement. The deadline for satisfying the requirement is the date of a practitioners’ next scheduled DEA registration submission on or after June 27, 2023. This present course provides two of the eight hours of the requirement.
Topics in this course include the following: Prescription Drug Monitoring Program’s (PDMP) effect on opiate prescribing, proper prescription writing, DEA schedule of controlled substances, prescription drug abuse crisis, opioid prescribing and disposal, alternatives to opioid therapy for pain control, pediatric dosings where applicable; opiates, NSAIDs and interactions with other drugs, and opioid dependency and patient (parent) education.

Course Objectives:

After completing the course, the participants will be able to:

     ⦁ Write a prescription in proper format for an opioid and nonopioid pain reliever
     ⦁ List the nonopioid drugs as opioid alternatives for pain control
     ⦁ List the five DEA schedules of drugs with important drugs within each
     ⦁ Describe best practices for handling and disposal of controlled substances
     ⦁ List three conditions in which NSAIDs such as ibuprofen are contraindicated
     ⦁ List the three waves of rise of opioid overdose deaths since 2000.

Florida Academy of Pediatric Dentistry is an ADA CERP Recognized Provider approved by American Academy of Pediatric Dentistry. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at www.ada.org/cerp.

* has no relevant financial relationships to disclose

Members of the CE planning committee have no relevant financial relationships to disclose.

Please contact Dr. Michael Roseff 954-292-0440 for any technical concerns for Zoom Meeting